United Therapeutics Corporation

8-K Director or officer change; Regulation FD disclosure Jul 23, 2026 8-K Director or officer change; Shareholder vote results Jun 29, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Other events Mar 30, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 9, 2026 8-K Regulation FD disclosure Mar 2, 2026 8-K Results of operations (earnings release) Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jan 22, 2026 8-K Results of operations (earnings release) Oct 29, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Other events Sep 2, 2025 8-K Entered a material agreement; Regulation FD disclosure Aug 1, 2025 8-K Results of operations (earnings release) Jul 30, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Director or officer change; Shareholder vote results Jun 27, 2025 8-K Results of operations (earnings release) Apr 30, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Apr 28, 2025 8-K Results of operations (earnings release) Feb 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Results of operations (earnings release) Oct 30, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release) Jul 31, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure Jun 27, 2024 8-K Results of operations (earnings release) May 1, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation Mar 29, 2024 8-K Entered a material agreement; Regulation FD disclosure Mar 25, 2024 8-K Other events Feb 27, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 21, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Other events Dec 20, 2023 8-K Other events Nov 29, 2023 8-K Results of operations (earnings release) Nov 1, 2023 10-Q Quarter ended 2023-09-30 Nov 1, 2023 8-K Results of operations (earnings release) Aug 2, 2023